Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant Epilepsies
Clinical trial NCT04406948 · WITHDRAWN
Trial details
- NCT number
- NCT04406948
- Sponsor
- MGC Pharmaceuticals d.o.o
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-30
- Primary completion
- 2024-05-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.